Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 418 articles:
HTML format



Single Articles


    July 2021
  1. MEDERACKE I, Wiestler M, Wedemeyer H
    An unusual cause of erythema on both lower legs in a patient with Crohn s disease.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03249.
    PubMed    


  2. LECHNER K, Mott S, Al-Saifi R, Knipfer L, et al
    Targeting of the Tec kinase ITK drives resolution of T cell-mediated colitis and emerges as potential therapeutic option in ulcerative colitis.
    Gastroenterology. 2021 Jul 3. pii: S0016-5085(21)03186.
    PubMed     Abstract available


  3. BEN-TOV A, Banon T, Chodick G, Kariv R, et al
    BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.
    Gastroenterology. 2021 Jul 2. pii: S0016-5085(21)03233.
    PubMed    


  4. PAPA A, Gasbarrini A, Lopetuso LR
    Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients.
    Gastroenterology. 2021;161:368-369.
    PubMed    


    June 2021
  5. REINISCH W
    PEG and mucosal biofilms in irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03167.
    PubMed    


  6. BAUMGARTNER M, Lang M, Holley H, Crepaz D, et al
    Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 16. pii: S0016-5085(21)03138.
    PubMed     Abstract available


  7. PEYRIN-BIROULET L, Loftus EV Jr, Colombel JF, Danese S, et al
    Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY.
    Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03126.
    PubMed     Abstract available


  8. HADI YB, Thakkar S, Shah-Khan SM, Hutson W, et al
    COVID-19 vaccination is safe and effective in patients with inflammatory bowel disease: Analysis of a large multi-institutional research network in United States.
    Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03125.
    PubMed    


  9. MAHMUD N, Weiss A, Trivedi C, Yang YX, et al
    Risk of Venous Thromboembolism among Inflammatory Bowel Disease patients who contract SARS-CoV-2.
    Gastroenterology. 2021 Jun 14. pii: S0016-5085(21)03123.
    PubMed    


  10. NARULA N, Wong ECL, Dehghan M, Marshall JK, et al
    BRIEF COMMUNICATION: Does High Inflammatory Diet Increase Risk of Inflammatory Bowel Disease? Results from the Prospective Urban Rural Epidemiology (PURE) study: A Prospective Cohort Study.
    Gastroenterology. 2021 Jun 9. pii: S0016-5085(21)03096.
    PubMed    


  11. BARBERIO B, Buda A, Savarino EV
    Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
    Gastroenterology. 2021;160:2626-2627.
    PubMed    


  12. BEZZIO C, Saibeni S
    Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist.
    Gastroenterology. 2021;160:2625-2626.
    PubMed    


  13. MAGO S, Vaziri H, Tadros M
    The Usefulness of Fecal Calprotectin in the era of the COVID-19 Pandemic.
    Gastroenterology. 2021;160:2623-2625.
    PubMed    


    May 2021
  14. KHAN N, Mahmud N
    Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03066.
    PubMed     Abstract available


  15. PAI N, Popov J, Hill L, Hartung E, et al
    Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects.
    Gastroenterology. 2021 May 4. pii: S0016-5085(21)00739.
    PubMed    


  16. STALGIS C, Deepak P, Mehandru S, Colombel JF, et al
    Rational Combination Therapy to Overcome the Plateau of Drug Efficacy in Inflammatory Bowel Disease.
    Gastroenterology. 2021 May 4. pii: S0016-5085(21)00740.
    PubMed    


  17. OCCHIPINTI V, Saibeni S, Sampietro GM, Pastorelli L, et al
    Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD: A Domino Effect.
    Gastroenterology. 2021;160:2196-2197.
    PubMed    


    April 2021
  18. AGRAWAL M, Spencer EA, Colombel JF, Ungaro RC, et al
    Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists.
    Gastroenterology. 2021 Apr 30. pii: S0016-5085(21)00734.
    PubMed     Abstract available


  19. RAJAMAKI K, Taira A, Katainen R, Valimaki N, et al
    Genetic and epigenetic characteristics of inflammatory bowel disease associated colorectal cancer.
    Gastroenterology. 2021 Apr 27. pii: S0016-5085(21)00680.
    PubMed     Abstract available


  20. AGRAWAL M, Hillenbrand CM, Allin KH, Torres J, et al
    Early life greenspace and the risk of pediatric-onset inflammatory bowel disease: insights into the link between environmental and human health.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00644.
    PubMed    


  21. TAXONERA C, Alba C, Olivares D
    What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?
    Gastroenterology. 2021;160:1901-1902.
    PubMed    


  22. MAGRO F, Dias CC, Morato M
    Aminosalicylates and COVID-19: Facts or Coincidences?
    Gastroenterology. 2021;160:1884-1885.
    PubMed    


    March 2021
  23. SOLITANO V, Vuitton L, Peyrin-Biroulet L, Danese S, et al
    The Evolution of Biologics Administration From Intravenous to Subcutaneous: Treatments for Inflammatory Bowel Disease Goes Home.
    Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00548.
    PubMed    


  24. SHIRAI T, Kakuta Y, Fujii H
    Distinct autoantibodies against endothelial protein C receptor in ulcerative colitis.
    Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00547.
    PubMed    


  25. UNGER LW, Kaser A
    Is IL-6 back in trans signalling for inflammatory bowel disease?
    Gastroenterology. 2021 Mar 19. pii: S0016-5085(21)00539.
    PubMed    


  26. SCHREIBER S, Ben-Horin S, Leszczyszyn J, Dudkowiak R, et al
    Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease.
    Gastroenterology. 2021 Mar 4. pii: S0016-5085(21)00474.
    PubMed     Abstract available


  27. SCHREIBER S, Aden K, Bernardes JP, Conrad C, et al
    Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease.
    Gastroenterology. 2021 Mar 2. pii: S0016-5085(21)00467.
    PubMed     Abstract available


  28. VERMEIRE S, Hebuterne X, Tilg H, De Hertogh G, et al
    Induction and long-term follow-up with ABX464 for moderate-to-severe ulcerative colitis: Results of phase 2a trial.
    Gastroenterology. 2021 Mar 1. pii: S0016-5085(21)00459.
    PubMed    


  29. ILIEV ID, Cadwell K
    Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:1050-1066.
    PubMed     Abstract available


    February 2021
  30. BENCHIMOL EI, Tse F, Carroll MW, deBruyn JC, et al
    TEMPORARY REMOVAL: Canadian Association of Gastroenterology CLINICAL Practice Guideline For Immunizations in Patients with Inflammatory Bowel Disease (IBD). Part 2: Inactivated Vaccines.
    Gastroenterology. 2021 Feb 19. pii: S0016-5085(21)00427.
    PubMed     Abstract available


  31. MA C, Sedano R, Almradi A, Casteele NV, et al
    An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials.
    Gastroenterology. 2021 Feb 18. pii: S0016-5085(21)00423.
    PubMed     Abstract available


  32. KUWADA T, Shiokawa M, Kodama Y, Ota S, et al
    Identification of an Anti-Integrin alphavbeta6 Autoantibody in Patients with Ulcerative Colitis.
    Gastroenterology. 2021 Feb 11. pii: S0016-5085(21)00406.
    PubMed     Abstract available


  33. COHEN RD, Feuerstein JD, Rubin DT
    REPLY to letters to the editor regarding manuscript Rubin DT, Feuerstein JD, Wang AY, Cohen RD, AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary, Gastroenterology (2020).
    Gastroenterology. 2021 Feb 6. pii: S0016-5085(21)00399.
    PubMed    


  34. NOWAK JK, Kalla R, Satsangi J
    SARS-CoV-2 entry molecules' expression and COVID-19 in inflammatory bowel disease: is the gut critical?
    Gastroenterology. 2021 Feb 4. pii: S0016-5085(21)00350.
    PubMed    


  35. KHANNA R, Afif W
    Ustekinumab for Ulcerative colitis.
    Gastroenterology. 2021 Feb 3. pii: S0016-5085(21)00340.
    PubMed    


  36. POTDAR AA, Dube S, Naito T, Li K, et al
    Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
    Gastroenterology. 2021;160:809-822.
    PubMed     Abstract available


  37. TE GROEN M, Derks MEW, Kuijpers CCHJ, Nagtegaal ID, et al
    Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study.
    Gastroenterology. 2021;160:935-937.
    PubMed    


  38. PATANKAR JV, Chiriac MT, Lehmann M, Kuhl AA, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling.
    Gastroenterology. 2021;160:925-928.
    PubMed    


  39. MELMED GY, Rubin DT, McGovern DPB
    Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
    Gastroenterology. 2021;160:639-644.
    PubMed    


  40. BURGUENO JF, Fritsch J, Gonzalez EE, Landau KS, et al
    Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
    Gastroenterology. 2021;160:797-808.
    PubMed     Abstract available


    January 2021
  41. ZILBAUER M, Heuschkel R
    Reply to Lee et al.: Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
    Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00317.
    PubMed    


  42. MESERVE J, Singh S
    Pathologist, meet Picasso! Virtual chromoendoscopy for detecting histologic remission in ulcerative colitis.
    Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00318.
    PubMed    


  43. TAKENAKA K, Ohtsuka K, Fujii T, Oshima S, et al
    Deep neural network accurately predicts prognosis of ulcerative colitis using endoscopic images.
    Gastroenterology. 2021 Jan 21. pii: S0016-5085(21)00278.
    PubMed    


  44. RANDOLPH GJ, Czepielewski RS
    Response to: Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00270.
    PubMed    


  45. PINTO-SANCHEZ MI, Seiler C, Verdu EF
    Reply to: Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00273.
    PubMed    


  46. BRAND EC, Klaassen MAY, Gacesa R, Vila AV, et al
    Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients.
    Gastroenterology. 2021 Jan 18. pii: S0016-5085(21)00097.
    PubMed     Abstract available


  47. BHAT S, Farraye FA, Hayney MS, Caldera F, et al
    How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease.
    Gastroenterology. 2021 Jan 15. pii: S0016-5085(21)00093.
    PubMed    


  48. KHAN N, Yang YX
    Adherence of Infusible Biologics During the Time of COVID-19 Among Patients with Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study.
    Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00071.
    PubMed    


  49. LEE JC, Lyons PA, McKinney EF
    Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
    Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00081.
    PubMed    


  50. LE BERRE C, Peyrin-Biroulet L
    Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00016.
    PubMed     Abstract available


  51. CHEN E, Chuang LS, Giri M, Villaverde N, et al
    Inflamed ulcerative colitis regions associated to MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00024.
    PubMed     Abstract available


  52. SUAREZ-FARINAS M, Tokuyama M, Wei G, Huang R, et al
    Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.
    Gastroenterology. 2021;160:287-301.
    PubMed     Abstract available


  53. LEE M, Chang EB
    Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Gastroenterology. 2021;160:524-537.
    PubMed     Abstract available


  54. KELLERMAYER R, van der Laan M
    Validation of Predictive Models in Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:21-22.
    PubMed    


  55. NORSA L, D'Antiga L
    Reply.
    Gastroenterology. 2021;160:474-475.
    PubMed    


  56. SAZONOVS A, Ahmad T, Anderson CA
    Underpowered PANTS: A Response to the Conclusions of "Extended Analysis Identifies Drug-Specific Association of Two Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab".
    Gastroenterology. 2021;160:470-471.
    PubMed    


  57. CASADEI C, Barberio B, Savarino E
    A Peculiar Cutaneous Manifestation in a Patient With Crohn's Disease.
    Gastroenterology. 2021;160:e1-e3.
    PubMed    


  58. ZHANG J, Hoedt EC, Liu Q, Berendsen E, et al
    Elucidation of Proteus mirabilis as a Key Bacterium in Crohn's Disease Inflammation.
    Gastroenterology. 2021;160:317-330.
    PubMed     Abstract available


  59. RICCIUTO A, Aardoom M, Orlanski-Meyer E, Navon D, et al
    Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.
    Gastroenterology. 2021;160:403-436.
    PubMed     Abstract available


    December 2020
  60. UNGARO RC, Kappelman MD, Rubin DT, Colombel JF, et al
    COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions.
    Gastroenterology. 2020 Dec 30. pii: S0016-5085(20)35600.
    PubMed    


  61. TIAN Y, Zuo L
    Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35599.
    PubMed    


  62. TSE CS, Deepak P, Papadakis K
    Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35594.
    PubMed    


  63. WIJNANDS AM, de Jong ME, Lutgens MWMD, Hoentjen F, et al
    Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35587.
    PubMed     Abstract available


  64. SHIMIZU MS, Matsuo T, Mori N
    A rare manifestation associated with a urinary tract infection in a patient with ulcerative colitis.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35566.
    PubMed    


  65. TURNER D, Ricciuto A, Lewis A, D'Amico F, et al
    STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35572.
    PubMed     Abstract available


  66. DEVLIN JC, Axelrad J, Hine AM, Chang S, et al
    Single Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells from Ulcerative Colitis Patients.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35571.
    PubMed     Abstract available


  67. IACUCCI M, Smith SC, Bazarova A, Shivaji UN, et al
    An international multicenter real-life prospective study of electronic chromoendoscopy score PICaSSO in Ulcerative Colitis.
    Gastroenterology. 2020 Dec 18. pii: S0016-5085(20)35563.
    PubMed     Abstract available


  68. KIM ES, Tarassishin L, Eisele C, Barre A, et al
    Longitudinal Changes in Fecal Calprotectin Levels among Pregnant Women with and without Inflammatory Bowel Disease and Their Babies.
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35532.
    PubMed     Abstract available


  69. VERSTOCKT B, Torres J
    Point-of-care intestinal ultrasound: prime time for the management of ulcerative colitis?
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35541.
    PubMed    


  70. GALIPEAU HJ, Caminero A, Turpin W, Bermudez-Brito M, et al
    Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis.
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35533.
    PubMed     Abstract available


  71. ROSEN MJ
    Could a Small Population of Epithelial Cells Get "Tuft" With Crohn's Disease?
    Gastroenterology. 2020;159:2025-2027.
    PubMed    


  72. KONG L, Lloyd-Price J, Vatanen T, Seksik P, et al
    Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
    Gastroenterology. 2020;159:2193-2202.
    PubMed     Abstract available


  73. BANERJEE A, Herring CA, Chen B, Kim H, et al
    Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation.
    Gastroenterology. 2020;159:2101-2115.
    PubMed     Abstract available


  74. TURPIN W, Lee SH, Raygoza Garay JA, Madsen KL, et al
    Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.
    Gastroenterology. 2020;159:2092-2100.
    PubMed     Abstract available


  75. COURTET A, Lemale J, Carra MC
    Generalized Gingival Hyperplasia and Rectorrhagia in a 13-Year-Old Boy.
    Gastroenterology. 2020;159:2030-2033.
    PubMed    


  76. ANGELINO G, Francalanci P, Tambucci R
    Terminal Ileum Thickening and Mucosal Ulcers in a Boy With Neurofibromatosis Type 1.
    Gastroenterology. 2020;159:e9-e11.
    PubMed    


    November 2020
  77. MAHADEVAN U, Long MD, Kane SV, Roy A, et al
    Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Nov 20. pii: S0016-5085(20)35441.
    PubMed     Abstract available


  78. TAXONERA C, Fisac J, Alba C
    Can COVID-19 trigger de novo inflammatory bowel disease?
    Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35424.
    PubMed    


  79. FAIRBRASS KM, Gracie DJ, Ford AC
    In the Face of Adversity: Is Resilience Training a New Target for Inflammatory Bowel Disease Therapy?
    Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35417.
    PubMed    


  80. TORRES J, Riddle M, Colombel JF
    Answer to the letter by Rodriguez-Lago et al: Pre-inflammatory bowel disease: back to the future.
    Gastroenterology. 2020 Nov 4. pii: S0016-5085(20)35363.
    PubMed    


  81. KOCHAR B, Ananthakrishnan AN
    Reply.
    Gastroenterology. 2020;159:1993-1994.
    PubMed    


  82. ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
    Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.
    Gastroenterology. 2020;159:1982-1984.
    PubMed    


  83. PARLATO M, Nian Q, Charbit-Henrion F, Ruemmele FM, et al
    Loss-of-Function Mutation in PTPN2 Causes Aberrant Activation of JAK Signaling Via STAT and Very Early Onset Intestinal Inflammation.
    Gastroenterology. 2020;159:1968-1971.
    PubMed    


  84. HUANG LH, Deepak P, Ciorba MA, Mittendorfer B, et al
    Postprandial Chylomicron Output and Transport Through Intestinal Lymphatics Are Not Impaired in Active Crohn's Disease.
    Gastroenterology. 2020;159:1955-1957.
    PubMed    


  85. SPALINGER MR, Sayoc-Becerra A, Santos AN, Shawki A, et al
    PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function.
    Gastroenterology. 2020;159:1763-1777.
    PubMed     Abstract available


    October 2020
  86. NAITO T, Botwin GJ, Haritunians T, Li D, et al
    Prevalence and Effect of Genetic Risk of Thrombo-embolic Disease in Inflammatory Bowel Disease.
    Gastroenterology. 2020 Oct 19. pii: S0016-5085(20)35276.
    PubMed     Abstract available


  87. GOTTLIEB K, Requa J, Karnes W, Chandra Gudivada R, et al
    Central reading of ulcerative colitis clinical trial videos using neural networks.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35283.
    PubMed     Abstract available


  88. BOSSUYT P, De Hertogh G, Eelbode T, Vermeire S, et al
    Computer aided diagnosis with monochromatic light endoscopy for scoring histological remission in ulcerative colitis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35246.
    PubMed    


  89. ANANTHAKRISHNAN AN, Nguyen GC, Bernstein CN
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in the Elderly: Expert Review.
    Gastroenterology. 2020 Oct 1. pii: S0016-5085(20)35219.
    PubMed    


  90. GARG M, Christensen B, Lubel JS
    Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?
    Gastroenterology. 2020;159:1623-1624.
    PubMed    


  91. PARIGI TL, Bonifacio C, Danese S
    Is It Crohn's Disease?
    Gastroenterology. 2020;159:1244-1246.
    PubMed    


  92. TAKENAKA K, Ohtsuka K, Suzuki K, Watanabe M, et al
    Reply.
    Gastroenterology. 2020;159:1626-1627.
    PubMed    


  93. GORDON M, Guyatt G
    Assessment of Evidence Quality in Inflammatory Bowel Disease Guidance: The Use and Misuse of GRADE.
    Gastroenterology. 2020;159:1209-1215.
    PubMed    


  94. STENGEL ST, Fazio A, Lipinski S, Jahn MT, et al
    Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
    Gastroenterology. 2020;159:1357-1374.
    PubMed     Abstract available


  95. RAWAT M, Nighot M, Al-Sadi R, Gupta Y, et al
    IL1B Increases Intestinal Tight Junction Permeability by Up-regulation of MIR200C-3p, Which Degrades Occludin mRNA.
    Gastroenterology. 2020;159:1375-1389.
    PubMed     Abstract available


    September 2020
  96. KELLY CR, Yen EF, Grinspan AM, Kahn SA, et al
    Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35221.
    PubMed     Abstract available


  97. MEYER EO, Aardoom M, Ricciuto A, Navon D, et al
    Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements from PIBD-Ahead Program.
    Gastroenterology. 2020 Sep 22. pii: S0016-5085(20)35206.
    PubMed     Abstract available


  98. ABREU MT, Sandborn WJ
    Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design.
    Gastroenterology. 2020 Sep 19. pii: S0016-5085(20)35168.
    PubMed    


  99. RODRIGUEZ-LAGO I, Marigorta UM, Acosta MB
    Preclinical inflammatory bowel disease: back to the future.
    Gastroenterology. 2020 Sep 12. pii: S0016-5085(20)35152.
    PubMed    


  100. PAUL S, Roblin X
    The Nightmare Monitoring of JAKinhibs.
    Gastroenterology. 2020;159:1188-1189.
    PubMed    


  101. TILG H, D'Haens G
    How to Manage Crohn's Disease After Ileocolonic Resection?
    Gastroenterology. 2020;159:816-820.
    PubMed    


  102. KANG JW, Yan J, Ranjan K, Zhang X, et al
    Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation.
    Gastroenterology. 2020;159:1051-1067.
    PubMed     Abstract available


  103. KREISS L, Thoma OM, Dilipkumar A, Carle B, et al
    Label-Free In Vivo Histopathology of Experimental Colitis via 3-Channel Multiphoton Endomicroscopy.
    Gastroenterology. 2020;159:832-834.
    PubMed    


  104. HALL CHT, Lee JS, Murphy EM, Gerich ME, et al
    Creatine Transporter, Reduced in Colon Tissues From Patients With Inflammatory Bowel Diseases, Regulates Energy Balance in Intestinal Epithelial Cells, Epithelial Integrity, and Barrier Function.
    Gastroenterology. 2020;159:984-998.
    PubMed     Abstract available


  105. PINTO-SANCHEZ MI, Seiler CL, Santesso N, Alaedini A, et al
    Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;159:884-903.
    PubMed     Abstract available


    August 2020
  106. NORSA L, Cosimo P, Indriolo A, Sansotta N, et al
    Asymptomatic SARS-CoV-2 infection in patients with inflammatory bowel disease under biologic treatment.
    Gastroenterology. 2020 Aug 26. pii: S0016-5085(20)35117.
    PubMed    


  107. LI K, Marano C, Zhang H, Yang F, et al
    Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
    Gastroenterology. 2020 Aug 24. pii: S0016-5085(20)35107.
    PubMed     Abstract available


  108. HERNDON JS, Vitta S, Weber FH Jr
    Marked Eosinophilia in a 27-Year-Old Woman with Recent Onset Ulcerative Colitis.
    Gastroenterology. 2020 Aug 20. pii: S0016-5085(20)35069.
    PubMed    


  109. GASPARETTO M, Payne F, Nayak K, Kraiczy J, et al
    Transcription and DNA Methylation patterns of blood derived CD8(+) T cells are associated with age and Inflammatory Bowel Disease but do not predict prognosis.
    Gastroenterology. 2020 Aug 16. pii: S0016-5085(20)35056.
    PubMed     Abstract available


  110. BOSSUYT P, Vermeire S, Bisschops R
    Assessing disease activity in ulcerative colitis using artificial intelligence: can "equally good" be seen as "better"?
    Gastroenterology. 2020 Aug 13. pii: S0016-5085(20)35044.
    PubMed    


  111. WALSHE M, Silverberg MS, Targownik LE
    What Constitutes Frailty In Inflammatory Bowel Disease?
    Gastroenterology. 2020 Aug 12. pii: S0016-5085(20)35045.
    PubMed    


  112. JANSSON-KNODELL CL, Walker MJ, Fischer M
    Pancytopenia in a Young Male Patient with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Aug 7. pii: S0016-5085(20)35027.
    PubMed    


  113. HENN MR, O'Brien EJ, Diao L, Feagan BG, et al
    A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis.
    Gastroenterology. 2020 Aug 4. pii: S0016-5085(20)35012.
    PubMed     Abstract available


  114. BRENNER EJ, Ungaro RC, Gearry RB, Kaplan GG, et al
    Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
    Gastroenterology. 2020;159:481-491.
    PubMed     Abstract available


  115. STAHL E, Roda G, Dobbyn A, Hu J, et al
    Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases.
    Gastroenterology. 2020;159:549-561.
    PubMed     Abstract available


  116. POWELL DOHERTY RD, Liao H, Satsangi JJ, Ternette N, et al
    Extended Analysis Identifies Drug-Specific Association of 2 Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab.
    Gastroenterology. 2020;159:784-787.
    PubMed    


  117. APOSTOLOV R, Tan N, Vasudevan A
    Poor Bowel Preparation in Crohn's Disease.
    Gastroenterology. 2020;159:440-442.
    PubMed    


    July 2020
  118. BARBERIO B, Zingone F, Bertani L, Savarino E, et al
    The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients During COVID-19 Pandemic: Is It Really a Problem?
    Gastroenterology. 2020 Jul 17. pii: S0016-5085(20)34943.
    PubMed    


  119. KHANNA R, Zhou GY, Afif W
    Comparative Efficacy Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2020 Jul 15. pii: S0016-5085(20)34930.
    PubMed     Abstract available


  120. CAPPELLO M, Busacca A, Guida L
    The course of Covid 19 in Inflammatory Bowel Disease: protective role of TNF antagonists Response to: Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an
    Gastroenterology. 2020 Jul 6. pii: S0016-5085(20)34920.
    PubMed    


  121. MOCCIARO F, Scimeca D, Di Mitri R
    THE COURAGE TO RETURN TO EVERYDAY LIFE AT THE TIME OF COVID-19: THE POINT OF VIEW OF INFLAMMATORY BOWEL DISEASE PATIENTS NEEDING ENDOSCOPY.
    Gastroenterology. 2020 Jul 1. pii: S0016-5085(20)34913.
    PubMed    


  122. NORSA L, Indriolo A, Sansotta N, Cosimo P, et al
    Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.
    Gastroenterology. 2020;159:371-372.
    PubMed    


  123. BERNSTEIN CN
    New Biomarkers for Crohn's Disease.
    Gastroenterology. 2020;159:30-32.
    PubMed    


  124. UNO Y
    Why a Low FODMAP Diet Was Ineffective for IBS Symptoms in Quiescent Crohn's Disease.
    Gastroenterology. 2020;159:399.
    PubMed    


  125. ARDALAN ZS, Sparrow M, Gibson PR
    The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis.
    Gastroenterology. 2020;159:399-400.
    PubMed    


  126. PICKERT G, Wirtz S, Matzner J, Ashfaq-Khan M, et al
    Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis.
    Gastroenterology. 2020;159:257-272.
    PubMed     Abstract available


  127. EL-MATARY W, Nugent Z, Bernstein CN, Singh H, et al
    Long-term Cancer Risk in Patients With Pediatric-Onset Inflammatory Bowel Diseases in the Canadian Population.
    Gastroenterology. 2020;159:386-387.
    PubMed    


  128. NAIR N, Austin C, Curtin P, Gouveia C, et al
    Association Between Early-life Exposures and Inflammatory Bowel Diseases, Based on Analyses of Deciduous Teeth.
    Gastroenterology. 2020;159:383-385.
    PubMed    


  129. UNGARO RC, Yzet C, Bossuyt P, Baert FJ, et al
    Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.
    Gastroenterology. 2020;159:139-147.
    PubMed     Abstract available


  130. MULLIN GE, Chey WD, Crowe SE
    The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease.
    Gastroenterology. 2020;159:20-25.
    PubMed    


  131. HEALY ME, Boege Y, Hodder MC, Bohm F, et al
    MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice.
    Gastroenterology. 2020;159:183-199.
    PubMed     Abstract available


  132. TORRES J, Petralia F, Sato T, Wang P, et al
    Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
    Gastroenterology. 2020;159:96-104.
    PubMed     Abstract available


    June 2020
  133. YOON H, Jangi S, Dulai PS, Boland BS, et al
    Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020 Jun 22. pii: S0016-5085(20)34844.
    PubMed     Abstract available


  134. KHAN N, Patel D, Xie D, Pernes T, et al
    Adherence of infusible biologics during the time of COVID-19 among patients with Inflammatory Bowel Disease: A nationwide VA cohort study.
    Gastroenterology. 2020 Jun 20. pii: S0016-5085(20)34845.
    PubMed    


  135. KJAERGAARD VS, Jensen CB, Elmahdi R, Burisch J, et al
    Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Danish Cohort Study.
    Gastroenterology. 2020 Jun 18. pii: S0016-5085(20)34830.
    PubMed    


  136. BANGMA A, Voskuil MD, Weersma RK
    TNFalpha-antagonist use and mucosal inflammation are associated with increased intestinal expression of SARS-CoV-2 host protease TMPRSS2 in patients with inflammatory bowel disease.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34783.
    PubMed    


  137. BRAIN O, Satsangi J
    Therapeutic decisions in inflammatory bowel disease in the SARS-Cov-2 pandemic.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34775.
    PubMed    


  138. CHEN J, Peng X, Zhang M, Zhi M, et al
    Impact of medication discontinuation on patients with inflammatory bowel disease during the COVID-19 outbreak.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34779.
    PubMed    


  139. SINGH S, Khan A, Chowdhry M, Bilal M, et al
    Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study.
    Gastroenterology. 2020 Jun 6. pii: S0016-5085(20)34755.
    PubMed    


  140. RUETHER DF, Menz A, Manthey CF
    A Dishevelled Man with Inflammatory Bowel Disease and Signs of Infection.
    Gastroenterology. 2020 Jun 5. pii: S0016-5085(20)34749.
    PubMed    


  141. SABINO J, Torres J
    You Are What You Eat, But Can Diet Prevent Inflammatory Bowel Diseases?
    Gastroenterology. 2020;158:2304-2305.
    PubMed    


  142. ZIDAR N
    Histopathology of Fibrosis in Crohn's Disease: The Importance of Understanding Its Pathogenesis.
    Gastroenterology. 2020;158:2313-2314.
    PubMed    


  143. BOUHNIK Y, Louis E, Peyrin-Biroulet L
    Looking for Innovative Digital Solutions to Optimize Patient Recruitment in Inflammatory Bowel Disease Trials.
    Gastroenterology. 2020;158:2306-2307.
    PubMed    


  144. KOLLEN L, Werner O, Gavotto A
    Uncommon Cause of Chest Pain in a 9-Year-Old Boy With Crohn's Disease.
    Gastroenterology. 2020;158:2055-2057.
    PubMed    


  145. KOCHAR B, Cai W, Cagan A, Ananthakrishnan AN, et al
    Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2020;158:2104-2111.
    PubMed     Abstract available


  146. CROWLEY E, Warner N, Pan J, Khalouei S, et al
    Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center.
    Gastroenterology. 2020;158:2208-2220.
    PubMed     Abstract available


  147. SANDBORN WJ, Feagan BG, Loftus EV Jr, Peyrin-Biroulet L, et al
    Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
    Gastroenterology. 2020;158:2123-2138.
    PubMed     Abstract available


  148. LOEBENSTEIN M, Schulberg JD
    Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn's Disease.
    Gastroenterology. 2020;158:2069-2071.
    PubMed    


    May 2020
  149. LUKIN DJ, Kumar A, Hajifathalian K, Sharaiha RZ, et al
    Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2020 May 29. pii: S0016-5085(20)34738.
    PubMed    


  150. KHAN N, Patel D, Xie D, Lewis J, et al
    Impact of Anti-TNF and Thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: A Nationwide VA cohort study.
    Gastroenterology. 2020 May 29. pii: S0016-5085(20)34737.
    PubMed    


  151. LEES CW, Regueiro M, Mahadevan U
    Innovation in IBD Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease.
    Gastroenterology. 2020 May 28. pii: S0016-5085(20)34735.
    PubMed    


  152. KALINE A, Bram V, Anabela SR, Severine V, et al
    Ex vivo mimicking of inflammation in organoids derived from patients with ulcerative colitis.
    Gastroenterology. 2020 May 28. pii: S0016-5085(20)34736.
    PubMed    


  153. TRIVEDI PJ, Crothers H, Mytton J, Bosch S, et al
    Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age.
    Gastroenterology. 2020 May 20. pii: S0016-5085(20)34702.
    PubMed     Abstract available


  154. BHAT S, Farraye FA, Moss A
    Roles of Clinical Pharmacists in Caring for Patients with Inflammatory Bowel Disease during COVID-19.
    Gastroenterology. 2020 May 18. pii: S0016-5085(20)30677.
    PubMed    


  155. MITSIALIS V, Wall S, Liu P, Ordovas-Montanes J, et al
    Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Gastroenterology. 2020 May 16. pii: S0016-5085(20)30658.
    PubMed     Abstract available


  156. KOTZE PG, Peyrin-Biroulet L, Danese S
    Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic.
    Gastroenterology. 2020 May 15. pii: S0016-5085(20)30660.
    PubMed    


  157. KRZYSZTOF NJ, Christoffer LJ, Rahul K, Ricanek P, et al
    Age, inflammation and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease.
    Gastroenterology. 2020 May 12. pii: S0016-5085(20)30653.
    PubMed    


  158. MACALUSO FS, Orlando A
    Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?
    Gastroenterology. 2020 May 11. pii: S0016-5085(20)30619.
    PubMed    


  159. LO CH, Lochhead P, Khalili H, Song M, et al
    Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30603.
    PubMed     Abstract available


  160. GOWER-ROUSSEAU C, Fumery M, Pariente B
    Inflammatory bowel disease and the SARS-CoV-2 pandemic: more speed, less haste.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30605.
    PubMed    


  161. GUBATAN J, Levitte S, Balabanis T, Patel A, et al
    SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California.
    Gastroenterology. 2020 May 6. pii: S0016-5085(20)30601.
    PubMed    


  162. OLIVERA PA, Lasa JS, Bonovas S, Danese S, et al
    Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;158:1554-1573.
    PubMed     Abstract available


    April 2020
  163. D'AMICO F, Danese S, Peyrin-Biroulet L
    Inflammatory bowel disease management during the COVID-19 outbreak: a survey from the European Crohn's and Colitis Organization (ECCO).
    Gastroenterology. 2020 Apr 30. pii: S0016-5085(20)30578.
    PubMed    


  164. RODRIGUEZ-LAGO I, Ramirez de la Piscina P, Elorza A, Merino O, et al
    Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain).
    Gastroenterology. 2020 Apr 21. pii: S0016-5085(20)30560.
    PubMed    


  165. PARIGI TL, D'Amico F, Danese S
    Upadacitinib for Crohn's disease and ulcerative colitis treatment: hitting the selective JAKpot.
    Gastroenterology. 2020 Apr 17. pii: S0016-5085(20)30517.
    PubMed    


  166. HOLMER AK, Dulai PS
    Deep Learning Accurately Predicts Endoscopic and Histologic Remission in Ulcerative Colitis - What the Eye Doesn't See, the Artificial Mind Does Actually Know.
    Gastroenterology. 2020 Apr 11. pii: S0016-5085(20)30481.
    PubMed    


  167. RUBIN DT, Feuerstein JD, Wang AY, Cohen RD, et al
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
    Gastroenterology. 2020 Apr 10. pii: S0016-5085(20)30482.
    PubMed     Abstract available


  168. RUBIN DT, Abreu MT, Rai V, Siegel CA, et al
    Management of Patients with Crohn's Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting.
    Gastroenterology. 2020 Apr 6. pii: S0016-5085(20)30465.
    PubMed    


  169. FAYE AS, Colombel JF
    Age is Just a Number: How Frailty May Predict Outcomes Within Inflammatory Bowel Disease.
    Gastroenterology. 2020 Apr 2. pii: S0016-5085(20)30456.
    PubMed    



  170. Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.
    Gastroenterology. 2020;158:1462-1463.
    PubMed    


  171. ADEN K, Schreiber S, Rosenstiel P
    Reply.
    Gastroenterology. 2020;158:1512-1513.
    PubMed    


  172. CHEN J, Vitetta L
    Butyrate in Inflammatory Bowel Disease Therapy.
    Gastroenterology. 2020;158:1511.
    PubMed    


  173. JAZAYERI A, Nonga D, Rao M
    The Key to a Boy's Heart Is Through His Intestine.
    Gastroenterology. 2020;158:1226-1228.
    PubMed    


    March 2020
  174. BAMIAS G, Rivera-Nieves J, Mantzaris GJ
    Efficacy of IL12/23 blockade expands our therapeutic targets and challenges the old dogma in ulcerative colitis.
    Gastroenterology. 2020 Mar 18. pii: S0016-5085(20)30366.
    PubMed     Abstract available


  175. SPENCER EA, Helmus D, Telesco S, Colombel JF, et al
    Inflammatory Bowel Disease Clusters Within Affected Sibships in Ashkenazi Jewish Multiplex Families.
    Gastroenterology. 2020 Mar 18. pii: S0016-5085(20)30365.
    PubMed    


  176. FEUERSTEIN JD, Isaacs KL, Schneider Y, Siddique SM, et al
    Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
    Gastroenterology. 2020 Mar 10. pii: S0016-5085(20)30333.
    PubMed    


  177. DANESE S, Rimola J, Siegelman J
    Reply.
    Gastroenterology. 2020;158:1177-1178.
    PubMed    


  178. MACALUSO FS, Castiglione F, Rispo A, Orlando A, et al
    The VERSIFY Trial: What About Ultrasound Assessment?
    Gastroenterology. 2020;158:1176-1177.
    PubMed    


  179. GAUSMAN V, McNeill MB, Balzora S
    Facing Crohn's: A Rare Association.
    Gastroenterology. 2020;158:829-830.
    PubMed    


  180. APOSTOLOV R, Nicolaides S, Vasudevan A
    Complex Fistulizing Crohn's Disease.
    Gastroenterology. 2020;158:827-828.
    PubMed    


  181. PITTAYANON R, Lau JT, Leontiadis GI, Tse F, et al
    Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.
    Gastroenterology. 2020;158:930-946.
    PubMed     Abstract available


  182. JARDINE S, Anderson S, Babcock S, Leung G, et al
    Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Disease Caused by TTC7A Deficiency.
    Gastroenterology. 2020;158:1000-1015.
    PubMed     Abstract available


    February 2020
  183. SANDBORN WJ, Ghosh S, Panes J, Schreiber S, et al
    Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis.
    Gastroenterology. 2020 Feb 21. pii: S0016-5085(20)30241.
    PubMed     Abstract available


  184. PEREZ-JELDRES T, Alvarez-Lobos M, Nieves JR, Villablanca EJ, et al
    The cell circuitry of ulcerative colitis, a new view for a highly complex disease.
    Gastroenterology. 2020 Feb 14. pii: S0016-5085(20)30228.
    PubMed    


  185. TAKENAKA K, Ohtsuka K, Fujii T, Negi M, et al
    Development and Validation of a Deep Neural Network for Accurate Evaluation of Endoscopic Images From Patients with Ulcerative Colitis.
    Gastroenterology. 2020 Feb 11. pii: S0016-5085(20)30212.
    PubMed     Abstract available


  186. AGRAWAL M, Ungaro RC, Colombel JF
    New Blood Marker of Endoscopic Disease Activity-A Step Forward in Treating Crohn's Disease to Target?
    Gastroenterology. 2020;158:463-465.
    PubMed    


  187. FRITSCH J, Abreu MT
    Exposing the Achilles Heel of Antibiotic Therapy for Pouchitis Using Microbial Function and Composition.
    Gastroenterology. 2020;158:470-472.
    PubMed    


  188. D'HAENS G, Kelly O, Battat R, Silverberg MS, et al
    Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
    Gastroenterology. 2020;158:515-526.
    PubMed     Abstract available


  189. SONDHI AR, Nayak LJ, Mowers J
    Cachexia, Colitis, and Cancer.
    Gastroenterology. 2020;158:488-490.
    PubMed    


    January 2020
  190. CHIBA M, Tsuji T, Komatsu M
    How to Optimize Effects of Infliximab in Inflammatory Bowel Disease: Incorporation of Plant-based Diet: Infliximab Optimization Needs Dietary Fiber.
    Gastroenterology. 2020 Jan 14. pii: S0016-5085(20)30106.
    PubMed    


  191. FEUERSTEIN JD, Isaacs KL, Schneider Y, Siddique SM, et al
    AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30018.
    PubMed    


  192. HAMMOUDI N, Bondeelle L, Gornet JM
    An unusual case of chronic cough revealing ulcerative colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30083.
    PubMed    


  193. KENNEDY J, Satsangi J, Chapman TP
    Just another flare of ulcerative colitis?
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30094.
    PubMed    


  194. SINGH S, Allegretti JR, Siddique SM, Terdiman JP, et al
    AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30019.
    PubMed     Abstract available


  195. LIM J, Hammami MB, Mahadevan U
    Infliximab Use in a Child with Ulcerative Colitis and Prior in utero Exposure to Infliximab.
    Gastroenterology. 2020 Jan 8. pii: S0016-5085(20)30012.
    PubMed    


  196. KHALILI H, Burke KE, Roelstraete B, Sachs MC, et al
    Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study.
    Gastroenterology. 2020 Jan 8. pii: S0016-5085(20)30008.
    PubMed     Abstract available


  197. PARK SH, Park SH
    Simplified Magnetic Resonance Index of Activity for Crohn's Disease-Let's Try to Kick It Up a Notch.
    Gastroenterology. 2020;158:281-282.
    PubMed    


  198. WILLIET N, Jardin S, Roblin X
    The Simplified Magnetic Resonance Index of Activity (MARIA) for Crohn's Disease Is Strongly Correlated With the MARIA and Clermont Score: An External Validation.
    Gastroenterology. 2020;158:282-283.
    PubMed    


  199. SAZONOVS A, Kennedy NA, Moutsianas L, Heap GA, et al
    HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
    Gastroenterology. 2020;158:189-199.
    PubMed     Abstract available


  200. SEIDELIN JB, Riis LB, Butt RA
    Crohn's Disease With Progressive Renal Impairment.
    Gastroenterology. 2020;158:58-59.
    PubMed    


  201. GORDON IO, Bettenworth D, Bokemeyer A, Srivastava A, et al
    Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review.
    Gastroenterology. 2020;158:137-150.
    PubMed     Abstract available


    December 2019
  202. DANESE S
    New Drugs In The Ulcerative Colitis Pipeline: Prometheus Unbound.
    Gastroenterology. 2019 Dec 17. pii: S0016-5085(19)41924.
    PubMed    


  203. GRIMAUD F, Serrero M, Magalon J
    Adipose-Derived Therapeutic Products for the Management of Refractory Crohn's Fistula.
    Gastroenterology. 2019;157:1690-1691.
    PubMed    


  204. GUO Y, Bai AP
    Plasticity of Th17 Cells Contributes to Crohn's Disease.
    Gastroenterology. 2019;157:1689.
    PubMed    


  205. COOK L, Stahl M, Han X, Nazli A, et al
    Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Gastroenterology. 2019;157:1584-1598.
    PubMed     Abstract available


  206. HARRIS MS, Wichary J, Zadnik M, Reinisch W, et al
    Competition for Clinical Trials in Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1457-1461.
    PubMed    


  207. BITTAR JM, Burton K, Rahnama S
    Verrucous Plaques of the Buttocks, Perineum, and Umbilicus.
    Gastroenterology. 2019;157:1480-1482.
    PubMed    


  208. DEBOURDEAU A, Boivineau L, Iltache S
    The Little Beast That Pretended to Be a Severe Crohn's Disease.
    Gastroenterology. 2019;157:1483-1484.
    PubMed    


    November 2019
  209. VAZIRI H, Anderson JC
    Stool DNA for the Detection of High Grade Dysplasia and Adenocarcinoma in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2019 Nov 20. pii: S0016-5085(19)41584.
    PubMed    


  210. FUKUNAGA S, Kusaba Y, Tsuruta O
    Use of endocytoscopy for ulcerative colitis surveillance: A case study.
    Gastroenterology. 2019 Nov 15. pii: S0016-5085(19)41567.
    PubMed    


  211. SANDBORN WJ, Peyrin-Biroulet L, Zhang J, Chiorean M, et al
    Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients with Ulcerative Colitis.
    Gastroenterology. 2019 Nov 8. pii: S0016-5085(19)41526.
    PubMed     Abstract available


  212. TORRES J
    Prediction of Inflammatory Bowel Disease: A Step Closer?
    Gastroenterology. 2019 Nov 5. pii: S0016-5085(19)41515.
    PubMed    


  213. ALAMEEL T, Al Sulais E
    Ustekinumab and Pregnancy: Continue or Cease Before You Conceive?
    Gastroenterology. 2019;157:1435.
    PubMed    


  214. BERNSTEIN CN
    Reply.
    Gastroenterology. 2019;157:1443-1444.
    PubMed    


  215. MAHADEVAN U, Fisher S, Riley L, Chambers C, et al
    Reply.
    Gastroenterology. 2019;157:1435-1436.
    PubMed    


  216. SHAH SC
    Friend or Foe in Inflammatory Bowel Disease Pathogenesis: Not All Infections Are Equal.
    Gastroenterology. 2019;157:1441-1442.
    PubMed    


  217. ZHU Y, Johnson LA, Rubin JM, Appelman H, et al
    Strain-Photoacoustic Imaging as a Potential Tool for Characterizing Intestinal Fibrosis.
    Gastroenterology. 2019;157:1196-1198.
    PubMed    


  218. KUO WT, Shen L, Zuo L, Shashikanth N, et al
    Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression.
    Gastroenterology. 2019;157:1323-1337.
    PubMed     Abstract available


  219. BAR-YOSEPH H, Pressman S, Blatt A, Gerassy Vainberg S, et al
    Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies.
    Gastroenterology. 2019;157:1338-1351.
    PubMed     Abstract available


  220. GUNTHER C, Ruder B, Stolzer I, Dorner H, et al
    Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1310-1322.
    PubMed     Abstract available


  221. HINDRYCKX P, Jairath V, Zou G, Feagan BG, et al
    Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1233-1244.
    PubMed     Abstract available


  222. ADEN K, Rehman A, Waschina S, Pan WH, et al
    Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1279-1292.
    PubMed     Abstract available


    October 2019
  223. PAPAMICHAEL K, Cheifetz AS
    Is It Prime Time for Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease?
    Gastroenterology. 2019;157:922-924.
    PubMed    


  224. GONCZI L, Bessissow T, Lakatos P
    Ver(s)ifying the Efficacy of Vedolizumab Therapy on Mucosal Healing in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:925-927.
    PubMed    


  225. GERASIMIDIS K, Svolos V, Nichols B, Papadopoulou R, et al
    Reply.
    Gastroenterology. 2019;157:1161-1162.
    PubMed    


  226. PARAMSOTHY S, Kaakoush NO
    Reply.
    Gastroenterology. 2019;157:1165-1166.
    PubMed    


  227. ASHTON JJ, Beattie RM
    Treatment of Active Crohn's Disease With an Ordinary Food-Based Diet That Replicates Exclusive Enteral Nutrition.
    Gastroenterology. 2019;157:1160-1161.
    PubMed    


  228. ALVARADO DM, Chen B, Iticovici M, Thaker AI, et al
    Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.
    Gastroenterology. 2019;157:1093-1108.
    PubMed     Abstract available


  229. DANESE S, Sandborn WJ, Colombel JF, Vermeire S, et al
    Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Gastroenterology. 2019;157:1007-1018.
    PubMed     Abstract available


  230. LI K, Friedman JR, Chan D, Pollack P, et al
    Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1019-1031.
    PubMed     Abstract available


  231. DULAI PS, Peyrin-Biroulet L, Danese S, Sands BE, et al
    Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1032-1043.
    PubMed     Abstract available


  232. ASSA A, Matar M, Turner D, Broide E, et al
    Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring.
    Gastroenterology. 2019;157:985-996.
    PubMed     Abstract available


  233. LOWENBERG M, Vermeire S, Mostafavi N, Hoentjen F, et al
    Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:997-1006.
    PubMed     Abstract available


    September 2019
  234. COX SR, Lindsay JO, Fromentin S, Stagg AJ, et al
    Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Gastroenterology. 2019 Sep 27. pii: S0016-5085(19)41366.
    PubMed     Abstract available


  235. DE BACKER E, Bode H, Baert F
    New onset diffuse parenchymal lung disease in a 52-year old female with ulcerative colitis.
    Gastroenterology. 2019 Sep 24. pii: S0016-5085(19)41353.
    PubMed    


  236. SANDBORN WJ, Ferrante M, Bhandari BR, Berliba E, et al
    Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
    Gastroenterology. 2019 Sep 4. pii: S0016-5085(19)41300.
    PubMed     Abstract available


  237. XIAO L, Li XX, Chung HK, Kalakonda S, et al
    RNA-Binding Protein HuR Regulates Paneth Cell Function by Altering Membrane Localization of TLR2 via Post-transcriptional Control of CNPY3.
    Gastroenterology. 2019;157:731-743.
    PubMed     Abstract available


  238. PIOVANI D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, et al
    Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses.
    Gastroenterology. 2019;157:647-659.
    PubMed     Abstract available


    August 2019
  239. SANDBORN WJ, Baert F, Danese S, Krznaric Z, et al
    Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.
    Gastroenterology. 2019 Aug 27. pii: S0016-5085(19)41247.
    PubMed     Abstract available


  240. MONES RL
    Events Early in Life, But Not The Neonatal Period, Affect Risk For Later Development of Inflammatory Bowel Disease.
    Gastroenterology. 2019 Aug 20. pii: S0016-5085(19)41235.
    PubMed    


  241. SABINO J, Torres J, Colombel JF, Peter I, et al
    Neonatal life events and the risk of inflammatory bowel disease.
    Gastroenterology. 2019 Aug 20. pii: S0016-5085(19)41234.
    PubMed    


  242. MACK DR, Benchimol EI, Critch J, deBruyn J, et al
    Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease.
    Gastroenterology. 2019;157:320-348.
    PubMed     Abstract available


  243. LEVINE A, Wine E, Assa A, Sigall Boneh R, et al
    Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
    Gastroenterology. 2019;157:440-450.
    PubMed     Abstract available


  244. CHAPMAN TP, Tandon R, Brain O
    Another Case of Reflux Esophagitis?
    Gastroenterology. 2019;157:309-310.
    PubMed    


  245. ORDAS I, Rimola J, Alfaro I, Rodriguez S, et al
    Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's Disease.
    Gastroenterology. 2019;157:432-439.
    PubMed     Abstract available


    July 2019
  246. KELLERMAYER R
    Roseburia ssp.: Prime Candidates for Microbial Therapeutics in Inflammatory Bowel Disease.
    Gastroenterology. 2019 Jul 26. pii: S0016-5085(19)41122.
    PubMed    


  247. SMALLEY W, Falck-Ytter C, Carrasco-Labra A, Wani S, et al
    American Gastroenterological Association Guideline on Mild-to-Moderate Ulcerative Colitis on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
    Gastroenterology. 2019 Jul 11. pii: S0016-5085(19)41083.
    PubMed    


  248. DU M, Dong R, Zheng S
    Single-Cell RNA Sequencing of T Cells in Crohn's Disease.
    Gastroenterology. 2019;157:265-266.
    PubMed    


  249. ALBENBERG L, Brensinger CM, Wu Q, Gilroy E, et al
    A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn's Disease Flares.
    Gastroenterology. 2019;157:128-136.
    PubMed     Abstract available


  250. JASWANI TS, Hobson EM, Grider DJ
    A Complication of Crohn's Disease?
    Gastroenterology. 2019;157:31-33.
    PubMed    


    June 2019
  251. SABINO J, Lewis J, Colombel JF
    Treating Inflammatory Bowel Disease With Diet: A Taste Test.
    Gastroenterology. 2019 Jun 27. pii: S0016-5085(19)41036.
    PubMed    


  252. D'HAENS G, Rieder F, Feagan BG, Higgins PDR, et al
    Challenges in the Pathophysiology, Diagnosis and Management of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Gastroenterology. 2019 Jun 26. pii: S0016-5085(19)41035.
    PubMed     Abstract available


  253. ALTEPETER T, Wertheimer E, Lee JJ
    Expediting Drug Development for Pediatric Inflammatory Bowel Disease: A Workshop to Identify Barriers and Move Forward.
    Gastroenterology. 2019 Jun 20. pii: S0016-5085(19)41029.
    PubMed    


  254. CHEN JCY, Halawi H, Loftus CG
    New Ascites and Omental Thickening in Ulcerative Colitis.
    Gastroenterology. 2019 Jun 14. pii: S0016-5085(19)41014.
    PubMed    


  255. TORRES J, Peter I
    Neonatal Exposures and Risk of Inflammatory Bowel Disease: When Does the Clock Start Ticking?
    Gastroenterology. 2019 Jun 13. pii: S0016-5085(19)41007.
    PubMed    


  256. LIGHTNER AL
    The Present State and Future Direction of Regenerative Medicine for Perianal Crohn's Disease.
    Gastroenterology. 2019;156:2128-2130.
    PubMed    


  257. COHEN LJ, Cho JH, Gevers D, Chu H, et al
    Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases.
    Gastroenterology. 2019;156:2174-2189.
    PubMed     Abstract available


  258. SOMINENI HK, Venkateswaran S, Kilaru V, Marigorta UM, et al
    Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation.
    Gastroenterology. 2019;156:2254-2265.
    PubMed     Abstract available


  259. TIAN Y, Xu J, Li Y, Zhao R, et al
    MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice.
    Gastroenterology. 2019;156:2281-2296.
    PubMed     Abstract available


  260. DIGE A, Hougaard HT, Agnholt J, Pedersen BG, et al
    Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2019;156:2208-2216.
    PubMed     Abstract available


  261. BERNSTEIN CN, Burchill C, Targownik LE, Singh H, et al
    Events Within the First Year of Life, but Not the Neonatal Period, Affect Risk for Later Development of Inflammatory Bowel Diseases.
    Gastroenterology. 2019;156:2190-2197.
    PubMed     Abstract available


  262. SERRERO M, Grimaud F, Philandrianos C, Visee C, et al
    Long-term Safety and Efficacy of Local Microinjection Combining Autologous Microfat and Adipose-Derived Stromal Vascular Fraction for the Treatment of Refractory Perianal Fistula in Crohn's Disease.
    Gastroenterology. 2019;156:2335-2337.
    PubMed    


    May 2019
  263. GOLDBERG R, Scotta C, Cooper D, Nissim-Eliraz E, et al
    Correction of Defective T-Regulatory Cells From Patients With Crohn's Disease by Ex Vivo Ligation of Retinoic Acid Receptor-alpha.
    Gastroenterology. 2019;156:1775-1787.
    PubMed     Abstract available


    April 2019
  264. GRACIE DJ, Ford AC
    Depression, Antidepressants, and Inflammatory Bowel Disease: Implications for Future Models of Care.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36720.
    PubMed    


  265. FRIEDMAN S, Norgard BM
    Confirming Complexity: Assessing Environmental and Genetic Risk Factors for Inflammatory Bowel Disease.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36723.
    PubMed    


  266. KINNUCAN J, Binion D, Cross R, Evans E, et al
    Inflammatory Bowel Disease Care Referral Pathway.
    Gastroenterology. 2019 Apr 10. pii: S0016-5085(19)35665.
    PubMed    


  267. COWARD S, Clement F, Benchimol EI, Bernstein CN, et al
    Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.
    Gastroenterology. 2019;156:1345-1353.
    PubMed     Abstract available


  268. SVOLOS V, Hansen R, Nichols B, Quince C, et al
    Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
    Gastroenterology. 2019;156:1354-1367.
    PubMed     Abstract available


  269. MAHMOUD R, Shah SC, Ten Hove JR, Torres J, et al
    No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2019;156:1333-1344.
    PubMed     Abstract available


    March 2019
  270. GROSEN A, Bungum M, Hvas CL, Julsgaard M, et al
    Vedolizumab Does Not Impair Sperm DNA Integrity in Men With Inflammatory Bowel Disease.
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32509.
    PubMed    


  271. TSANG L, Banerjee N, Tabibian JH
    Not your typical inflammatory bowel disease flare: diarrhea and weight loss masquerading as recrudescence of ulcerative colitis.
    Gastroenterology. 2019 Mar 1. pii: S0016-5085(19)32503.
    PubMed    


  272. SCHEIBE K, Kersten C, Schmied A, Vieth M, et al
    Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
    Gastroenterology. 2019;156:1082-1097.
    PubMed     Abstract available


  273. HU X, Deng J, Yu T, Chen S, et al
    ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Gastroenterology. 2019;156:1098-1111.
    PubMed     Abstract available


  274. WYNNE B, McHugh L, Gao W, Keegan D, et al
    Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2019;156:935-945.
    PubMed     Abstract available


  275. FEHILY SR, Partsanis NM, Christensen B
    Cough in the Immunosuppressed Patient.
    Gastroenterology. 2019;156:e3-e4.
    PubMed    


    February 2019
  276. KORZENIK J
    Don't Worry, Be Happy: Psychological interventions in Inflammatory Bowel Disease.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30386.
    PubMed    


  277. PARISINOS CA
    Reply.
    Gastroenterology. 2019;156:824.
    PubMed    


  278. UNIKEN VENEMA WT, Voskuil MD, Vila AV, van der Vries G, et al
    Single-Cell RNA Sequencing of Blood and Ileal T Cells From Patients With Crohn's Disease Reveals Tissue-Specific Characteristics and Drug Targets.
    Gastroenterology. 2019;156:812-815.
    PubMed    


  279. OLEN O, Askling J, Sachs MC, Frumento P, et al
    Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population.
    Gastroenterology. 2019;156:614-622.
    PubMed     Abstract available


  280. TANG Y, Reissig S, Glasmacher E, Regen T, et al
    Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
    Gastroenterology. 2019;156:692-707.
    PubMed     Abstract available


    January 2019

  281. Mild-to-Moderate Ulcerative Colitis (UC) Clinical Decision Support Tool.
    Gastroenterology. 2019 Jan 23. pii: S0016-5085(19)30099.
    PubMed    


  282. CROSS R, Ko CW, Singh S
    Mild-to-Moderate Ulcerative Colitis Guideline.
    Gastroenterology. 2019 Jan 23. pii: S0016-5085(19)30097.
    PubMed    



  283. Management of Mild-to-Moderate Ulcerative Colitis: Patient Guide.
    Gastroenterology. 2019 Jan 19. pii: S0016-5085(19)30096.
    PubMed    


  284. MAHADEVAN U, Robinson C, Bernasko N, Boland B, et al
    Inflammatory Bowel Disease (IBD) in Pregnancy Clinical Care Pathway - A Report from the American Gastroenterological Association IBD Parenthood Project Working Group.
    Gastroenterology. 2019 Jan 16. pii: S0016-5085(18)35437.
    PubMed    


  285. YE L, Jiang Z, Cao Q
    Massive bleeding and perforation with endoscopic multiple deep ulcers in a patient with ulcerative colitis after colectomy.
    Gastroenterology. 2019 Jan 10. pii: S0016-5085(19)30029.
    PubMed    


  286. DE BOER NKH
    Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones.
    Gastroenterology. 2019;156:11-14.
    PubMed    


  287. LEHLE AS, Farin HF, Marquardt B, Michels BE, et al
    Intestinal Inflammation and Dysregulated Immunity in Patients With Inherited Caspase-8 Deficiency.
    Gastroenterology. 2019;156:275-278.
    PubMed    


  288. BORGERINK MMH, Weersma RK, Visschedijk MC
    A Case Report of a Young Adult With Progressive Bloody Diarrhea, Protein-Losing Enteropathy, and Extended Polyposis Coli.
    Gastroenterology. 2019;156:e10-e11.
    PubMed    


  289. HANAUER SB, Sandborn WJ, Lichtenstein GR
    Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
    Gastroenterology. 2019;156:36-42.
    PubMed     Abstract available


    December 2018
  290. KO CW, Singh S, Feuerstein JD, Falck-Ytter C, et al
    American Gastroenterological Association Institute Guideline on the Management of Mild-Moderate Ulcerative Colitis.
    Gastroenterology. 2018 Dec 18. pii: S0016-5085(18)35407.
    PubMed    


  291. SINGH S, Feuerstein JD, Binion DG, Tremaine WJ, et al
    American Gastroenterological Association Technical Review on the Management of Mild to Moderate Ulcerative Colitis.
    Gastroenterology. 2018 Dec 18. pii: S0016-5085(18)35406.
    PubMed     Abstract available


  292. PARAMSOTHY S, Nielsen S, Kamm MA, Deshpande NP, et al
    Specific Bacteria and Metabolites Associated with Response to Fecal Microbiota Transplantation in Patients with Ulcerative Colitis.
    Gastroenterology. 2018 Dec 6. pii: S0016-5085(18)35387.
    PubMed     Abstract available


  293. PHILIPOSE J, El Douaihy Y, Liliane DK
    An Unusual Case of Bloody Diarrhea in a Young Man.
    Gastroenterology. 2018;155:1695-1696.
    PubMed    


    November 2018
  294. SANDBORN WJ, Cyrille M, Hansen MB, Feagan BG, et al
    Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35283.
    PubMed     Abstract available


  295. BIANCHERI P, Watson AJM
    High Mucosal Plasma Cell Numbers and Low Serum TREM-1 Levels May Predict Nonresponsiveness to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35291.
    PubMed    


  296. LIU G, Jin S, Jiang Q
    Interleukin 6 receptor and inflammatory bowel disease: a Mendelian randomization study.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35266.
    PubMed    


  297. ARGYRIOU K, Khan M, Samuel S
    Multiple Unusual Ulcerated Skin Lesions in a Crohn's Disease Patient.
    Gastroenterology. 2018;155:e17-e18.
    PubMed    


    October 2018
  298. GODEFROY E, Alameddine J, Montassier E, Mathe J, et al
    Expression of CCR6 and CXCR6 by Gut-Derived CD4(+)/CD8alpha(+) T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:1205-1217.
    PubMed     Abstract available


  299. SHAH SC, Khalili H, Gower-Rousseau C, Olen O, et al
    Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries.
    Gastroenterology. 2018;155:1079-1089.
    PubMed     Abstract available


  300. RUTGEERTS P, Gasink C, Chan D, Lang Y, et al
    Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:1045-1058.
    PubMed     Abstract available


  301. GOLD SL, Magro C, Scherl E
    A Unique Infusion Reaction to Vedolizumab in a Patient With Crohn's Disease.
    Gastroenterology. 2018;155:981-982.
    PubMed    


    September 2018
  302. KELLY CP, Wilcox MH, Glerup H, Aboo N, et al
    Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease.
    Gastroenterology. 2018 Sep 15. pii: S0016-5085(18)34757.
    PubMed    


  303. SORRENTINO DR
    Therapeutic Targets in Inflammatory Bowel Disease: Are We Getting the Point Across?
    Gastroenterology. 2018 Sep 14. pii: S0016-5085(18)34773.
    PubMed    


  304. DULAI PS
    Methotrexate Monotherapy for Induction and Maintenance of Clinical Remission in Ulcerative Colitis: Dead on Arrival.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34940.
    PubMed    


  305. KANEIDER NC, Kaser A
    Personalized Treatment in Inflammatory Bowel Disease: For Another Time.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34937.
    PubMed    


  306. DULAI PS, Boland BS, Singh S, Chaudrey K, et al
    Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:687-695.
    PubMed     Abstract available


  307. MATRO R, Martin CF, Wolf D, Shah SA, et al
    Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
    Gastroenterology. 2018;155:696-704.
    PubMed     Abstract available


  308. CLERC F, Novokmet M, Dotz V, Reiding KR, et al
    Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:829-843.
    PubMed     Abstract available


  309. VANDUSSEN KL, Stojmirovic A, Li K, Liu TC, et al
    Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:815-828.
    PubMed     Abstract available


  310. CHEBLI JMF, de Oliveira Moreira B, da Rocha Ribeiro TC
    An Unusual Cause of Skin Rash in Crohn's Disease.
    Gastroenterology. 2018;155:618-620.
    PubMed    


    August 2018
  311. SHAH SC, Faith J, Colombel JF
    Microbial-host interactions in inflammatory bowel disease, functional bowel disease, obesity and obesity-related metabolic disease.
    Gastroenterology. 2018 Aug 31. pii: S0016-5085(18)34765.
    PubMed    


  312. KOUNTOURAS J, Polyzos SA, Deretzi G
    Multiple Bi-directionality Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2018 Aug 14. pii: S0016-5085(18)34877.
    PubMed    


  313. WEERSMA RK, Xavier RJ, Vermeire S, Barrett JC, et al
    "Multi-omics analyses to deliver the most effective treatment to every patient with inflammatory bowel disease".
    Gastroenterology. 2018 Aug 2. pii: S0016-5085(18)34827.
    PubMed    


  314. LE L, Fung BM, Tabibian JH
    Capsule Endoscopy for Refractory Iron Deficiency Anemia in Crohn's Disease: Captivating Pathology, Hybrid Therapy.
    Gastroenterology. 2018;155:276-277.
    PubMed    


  315. KIRCHGESNER J, Lemaitre M, Carrat F, Zureik M, et al
    Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:337-346.
    PubMed     Abstract available


    July 2018
  316. NISHIO M, Hirooka K, Doi Y
    Pulmonary Arterial Hypertension Associated With the Chinese Herb Indigo Naturalis for Ulcerative Colitis: It May Be Reversible.
    Gastroenterology. 2018 Jul 9. pii: S0016-5085(18)34649.
    PubMed    


  317. TELESCO SE, Brodmerkel C, Zhang H, Kim LL, et al
    Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-label Trial of Patients With Ulcerative Colitis.
    Gastroenterology. 2018 Jul 4. pii: S0016-5085(18)34719.
    PubMed     Abstract available


  318. LIU B, Dong K, Dong R
    The Diagnosis Effect of DNA Methylation in Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:229.
    PubMed    


  319. GENG H, Bu HF, Liu F, Wu L, et al
    In Inflamed Intestinal Tissues and Epithelial Cells, Interleukin 22 Signaling Increases Expression of H19 Long Noncoding RNA, Which Promotes Mucosal Regeneration.
    Gastroenterology. 2018;155:144-155.
    PubMed     Abstract available


  320. DANESE S, Bonovas S, Lopez A, Fiorino G, et al
    Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.
    Gastroenterology. 2018;155:76-87.
    PubMed     Abstract available


  321. DHILLON AS, Johnston EL, Sanderson JD
    A Case of Unusual Ileal Discoloration.
    Gastroenterology. 2018;155:e1-e2.
    PubMed    


    June 2018
  322. LYNN AM, Loftus EV Jr
    Illuminating the Black Box: The Real Risk of Serious Infection with Inflammatory Bowel Disease Therapies.
    Gastroenterology. 2018 Jun 29. pii: S0016-5085(18)34695.
    PubMed    


  323. HERFARTH H, Barnes EL, Valentine JF, Hanson J, et al
    Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis.
    Gastroenterology. 2018 Jun 29. pii: S0016-5085(18)34688.
    PubMed     Abstract available


  324. QUARANTA M, Wilson R, Serra EG, Pandey S, et al
    Genomics Identifies XIAP Deficiency in an Adult Patient With Inflammatory Bowel Disease: The Clinical and Health Care Impact.
    Gastroenterology. 2018 Jun 9. pii: S0016-5085(18)34529.
    PubMed    


  325. NUNES G, Patita M, Roque Ramos L
    An Uncommon Clinical Sign in a Patient with Ulcerative Colitis.
    Gastroenterology. 2018 Jun 5. pii: S0016-5085(18)34608.
    PubMed    


  326. AMININEJAD L, Charloteaux B, Theatre E, Liefferinckx C, et al
    Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's Disease.
    Gastroenterology. 2018;154:2165-2177.
    PubMed     Abstract available


  327. DENSON LA, Jurickova I, Karns R, Shaw KA, et al
    Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease.
    Gastroenterology. 2018;154:2097-2110.
    PubMed     Abstract available


  328. KHOURY T, Israeli E, Yaari S
    Unfolding the Diagnosis: Rare Endoscopic Features of Unusual Cause of Colitis.
    Gastroenterology. 2018;154:e7-e8.
    PubMed    


    May 2018
  329. PARISINOS CA, Serghiou S, Katsoulis M, George MJ, et al
    Variation in Interleukin 6 Receptor Gene Associates with Risk of Crohn's Disease and Ulcerative Colitis.
    Gastroenterology. 2018 May 15. pii: S0016-5085(18)34542.
    PubMed     Abstract available


  330. UHLIG HH, Booth C
    Inflammatory Bowel Disease and Immune Defects: A Spectrum of Genetic Variants and Clinical Pathogenicity.
    Gastroenterology. 2018 May 5. pii: S0016-5085(18)34485.
    PubMed    


  331. ADEDOKUN OJ, Xu Z, Gasink C, Jacobstein D, et al
    Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
    Gastroenterology. 2018;154:1660-1671.
    PubMed     Abstract available


  332. GRACIE DJ, Guthrie EA, Hamlin PJ, Ford AC, et al
    Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2018;154:1635-1646.
    PubMed     Abstract available


  333. YANG LS, Dowling D
    A Rare Complication of Infliximab.
    Gastroenterology. 2018;154:e5-e6.
    PubMed    


  334. DEBOURDEAU A, Bozon A, Altwegg R
    An Uncommon Cause of Feverish Swelling in a Patient With Crohn's Disease.
    Gastroenterology. 2018;154:1584-1585.
    PubMed    


    April 2018
  335. MAHAKKANUKRAUH P, Sinthubua A, Das S
    Methylated MicroRNA Biomarkers for Identifying Ulcerative Colitis-Associated Colorectal Cancers.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30311.
    PubMed    


  336. BOSCH S, de Meij TGJ, de Boer NK
    Altered Tryptophan Levels in Patients With Inflammatory Bowel Disease Owing to Colonic Leakage, Metabolism, or Malabsorption?
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30308.
    PubMed    


  337. CHARPENTIER C, Kottler D, Fite C, Pelletier AL, et al
    A Surprising Granulomatous Cheilitis.
    Gastroenterology. 2018;154:1239-1240.
    PubMed    


  338. D'HAENS G, Vermeire S, Lambrecht G, Baert F, et al
    Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
    Gastroenterology. 2018;154:1343-1351.
    PubMed     Abstract available


  339. SIMURINA M, de Haan N, Vuckovic F, Kennedy NA, et al
    Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;154:1320-1333.
    PubMed     Abstract available


  340. PANES J, Garcia-Olmo D, Van Assche G, Colombel JF, et al
    Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2018;154:1334-1342.
    PubMed     Abstract available


  341. ROY S, Esmaeilniakooshkghazi A, Patnaik S, Wang Y, et al
    Villin-1 and Gelsolin Regulate Changes in Actin Dynamics That Affect Cell Survival Signaling Pathways and Intestinal Inflammation.
    Gastroenterology. 2018;154:1405-1420.
    PubMed     Abstract available


    March 2018
  342. MAHADEVAN U, Silverberg MS
    Inflammatory Bowel Disease.
    Gastroenterology. 2018 Mar 14. pii: S0016-5085(18)30008.
    PubMed    


  343. BRUINING DH, Zimmermann EM, Loftus EV Jr., Sandborn WJ, et al
    Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease.
    Gastroenterology. 2018;154:1172-1194.
    PubMed     Abstract available


    February 2018
  344. LEY D, Jones J, Parrish J, Salih S, et al
    Methotrexate Reduces DNA Integrity in Sperm From Men with Inflammatory Bowel Disease.
    Gastroenterology. 2018 Feb 23. pii: S0016-5085(18)30229.
    PubMed     Abstract available


  345. PAPAMICHAEL K, Osterman MT, Siegel CA, Melmed GY, et al
    Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
    Gastroenterology. 2018 Feb 9. pii: S0016-5085(18)30006.
    PubMed    


  346. YE BD
    Introducing Traditional Herbal Medicine into Conventional Health Care in Treating Ulcerative Colitis: Primum Non Nocere.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30160.
    PubMed    


  347. MENEES SB, Almario CV, Spiegel BMR, Chey WD, et al
    Prevalence of and Factors Associated with Fecal Incontinence-Results From a Population-based Survey.
    Gastroenterology. 2018 Feb 3. pii: S0016-5085(18)30144.
    PubMed     Abstract available


  348. EVERHOV AH, Halfvarson J, Myrelid P, Sachs MC, et al
    Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Gastroenterology. 2018;154:518-528.
    PubMed     Abstract available


  349. HOWELL KJ, Kraiczy J, Nayak KM, Gasparetto M, et al
    DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
    Gastroenterology. 2018;154:585-598.
    PubMed     Abstract available


    January 2018
  350. JABOLI F, Pouillon L, Bossuyt P, Danese S, et al
    Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30101.
    PubMed    


  351. FEAGAN BG, Sands BE, Rossiter G, Li X, et al
    Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's Disease.
    Gastroenterology. 2018;154:61-64.
    PubMed     Abstract available


    December 2017
  352. LIU L, Nishihara R, Qian ZR, Tabung FK, et al
    Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.
    Gastroenterology. 2017;153:1517-1530.
    PubMed     Abstract available


  353. NIKOLAUS S, Schulte B, Al-Massad N, Thieme F, et al
    Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Gastroenterology. 2017;153:1504-1516.
    PubMed     Abstract available


    November 2017
  354. DAI C, Jiang M, Sun MJ
    Clostridium difficile Infection among Individuals With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Nov 23. pii: S0016-5085(17)36334.
    PubMed    


  355. NAGANUMA M, Sugimoto S, Mitsuyama K, Kobayashi T, et al
    Efficacy of Indigo naturalis in a Multicenter Randomized Controlled Trial of Patients with Ulcerative Colitis.
    Gastroenterology. 2017 Nov 22. pii: S0016-5085(17)36382.
    PubMed     Abstract available


  356. DULAI PS, Singh S, Ohno-Machado L, Sandborn WJ, et al
    Population Health Management for Inflammatory Bowel Disease.
    Gastroenterology. 2017 Nov 6. pii: S0016-5085(17)36337.
    PubMed     Abstract available


  357. KUMAR A, Chatterjee I, Gujral T, Alakkam A, et al
    Activation of Nuclear Factor-kappaB by Tumor Necrosis Factor in Intestinal Epithelial Cells and Mouse Intestinal Epithelia Reduces Expression of the Chloride Transporter SLC26A3.
    Gastroenterology. 2017;153:1338-1350.
    PubMed     Abstract available


  358. HEGAZY AN, West NR, Stubbington MJT, Wendt E, et al
    Circulating and Tissue-Resident CD4(+) T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation.
    Gastroenterology. 2017;153:1320-1337.
    PubMed     Abstract available


    October 2017
  359. GRACIE DJ, Ford AC
    A Bidirectional Relationship Between Symptom Reporting and Perceived Stress, But Not Disease Activity, in Inflammatory Bowel Disease: More Questions Than Answers?
    Gastroenterology. 2017 Oct 5. pii: S0016-5085(17)36194.
    PubMed    


  360. JULSGAARD M, Kjeldsen J, Bibby BM, Brock B, et al
    Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Oct 5. pii: S0016-5085(17)36132.
    PubMed    


    September 2017
  361. KESAR V, Swaminath A
    Hepatic masses in a patient in Inflammatory bowel disease.
    Gastroenterology. 2017 Sep 9. pii: S0016-5085(17)36140.
    PubMed    


  362. CHAPMAN S, El-Matary W
    Screening for Epstein-Barr Virus Status and Risk of Hemophagocytic Lymphohistiocytosis in Children With Inflammatory Bowel Disease on Azathioprine.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)36033.
    PubMed    


  363. BARNES EL, Herfarth HH
    The Usefulness of Serologic Testing for Epstein-Barr Virus Before Initiation of Therapy for Inflammatory Bowel Disease.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)36035.
    PubMed    


  364. VANDE CASTEELE N, Herfarth H, Katz J, Falck-Ytter Y, et al
    American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases.
    Gastroenterology. 2017;153:835-857.
    PubMed     Abstract available


  365. WELLMAN AS, Metukuri MR, Kazgan N, Xu X, et al
    Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota.
    Gastroenterology. 2017;153:772-786.
    PubMed     Abstract available


    August 2017
  366. TOIYAMA Y, Okugawa Y, Tanaka K, Araki T, et al
    A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-associated Colorectal Cancer.
    Gastroenterology. 2017 Aug 25. pii: S0016-5085(17)36070.
    PubMed     Abstract available


  367. TSAI JH, Rabinovitch PS, Huang D, Small T, et al
    Association of Aneuploidy and Flat Dysplasia With Development of High-Grade Dysplasia or Colorectal Cancer in Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Aug 23. pii: S0016-5085(17)36064.
    PubMed     Abstract available


  368. FEUERSTEIN JD, Nguyen GC, Kupfer SS, Falck-Ytter Y, et al
    Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35963.
    PubMed    



  369. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Clinical Decision Support Tool.
    Gastroenterology. 2017 Aug 1. pii: S0016-5085(17)35970.
    PubMed    


    July 2017

  370. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Patient Guide.
    Gastroenterology. 2017 Jul 31. pii: S0016-5085(17)35968.
    PubMed    


  371. SURESH S, Govani SM, Waljee AK
    Ten Hove JR et al. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy. Endoscopy. 2017 Feb;49(2):161-168.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35957.
    PubMed    


  372. POUILLON L, Bossuyt P, Peyrin-Biroulet L
    Tofacitinib is the right OCTAVE for ulcerative colitis.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35958.
    PubMed    


  373. PARLATO M, Charbit-Henrion F, Hayes P, Tiberti A, et al
    First Identification of Biallelic Inherited DUOX2 Inactivating Mutations as a Cause of Very Early Onset Inflammatory Bowel Disease.
    Gastroenterology. 2017 Jul 3. pii: S0016-5085(17)35484.
    PubMed    


  374. GONSKY R, Fleshner P, Deem RL, Biener-Ramanujan E, et al
    Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.
    Gastroenterology. 2017;153:219-232.
    PubMed     Abstract available


  375. DIETZ AB, Dozois EJ, Fletcher JG, Butler GW, et al
    Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2017;153:59-62.
    PubMed     Abstract available


  376. SANDS BE, Chen J, Feagan BG, Penney M, et al
    Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.
    Gastroenterology. 2017;153:77-86.
    PubMed     Abstract available


    June 2017
  377. DANESE S, Fiorino G, Peyrin-Biroulet L
    Filgotinib in Crohn Disease: JAK Is Back.
    Gastroenterology. 2017 Jun 24. pii: S0016-5085(17)35825.
    PubMed    


  378. HOLVOET T, Devriese S, Castermans K, Boland S, et al
    Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local Rho kinase inhibitor.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35798.
    PubMed     Abstract available


  379. CHANG J, Leong RW, Wasinger V, Ip M, et al
    Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Gastroenterology. 2017 Jun 7. pii: S0016-5085(17)35731.
    PubMed     Abstract available


  380. KANIS SL, van der Woude CJ
    Endoscopy for Inflammatory Bowel Disease During Pregnancy: Only When There Is a Strong Indication.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35603.
    PubMed    


    May 2017
  381. GRACIE DJ, Ford AC
    Irritable bowel syndrome-type symptoms are associated with psychological co-morbidity, reduced quality of life, and healthcare utilization in patients with inflammatory bowel disease.
    Gastroenterology. 2017 May 29. pii: S0016-5085(17)35679.
    PubMed    


  382. YADAV P, Ellinghaus D, Remy G, Freitag-Wolf S, et al
    Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.
    Gastroenterology. 2017 May 12. pii: S0016-5085(17)35596.
    PubMed     Abstract available


  383. SINGH H, Nugent Z, Yu BN, Lix LM, et al
    Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35554.
    PubMed     Abstract available


  384. MISRA R, Arebi N
    Re: Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35405.
    PubMed    


  385. LEONG RW, Ooi M, Corte C, Yau Y, et al
    Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:1337-1344.
    PubMed     Abstract available


    April 2017
  386. MAHADEVAN U
    How To Get an Education in Inflammatory Bowel Disease During Fellowship: Expectations and Realities.
    Gastroenterology. 2017 Apr 28. pii: S0016-5085(17)35540.
    PubMed    


    March 2017
  387. CHIRIAC MT, Buchen B, Wandersee A, Hundorfean G, et al
    Activation of Epithelial STAT1 by Interleukin 28 Controls Mucosal Healing in Mice with Colitis and is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Mar 22. pii: S0016-5085(17)30322.
    PubMed     Abstract available


  388. WEISMULLER TJ, Trivedi PJ, Bergquist A, Imam M, et al
    Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Gastroenterology. 2017 Mar 5. pii: S0016-5085(17)30236.
    PubMed     Abstract available


    February 2017
  389. HYAMS JS, Dubinsky MC, Baldassano RN, Colletti RB, et al
    Infliximab not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30148.
    PubMed     Abstract available


  390. ENNS RA, Hookey L, Armstrong D, Bernstein CN, et al
    Clinical Practice Guidelines for the Use of Video Capsule Endoscopy.
    Gastroenterology. 2017;152:497-514.
    PubMed     Abstract available


  391. HAWKEY CJ, Hommes DW
    Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?
    Gastroenterology. 2017;152:389-397.
    PubMed     Abstract available


  392. REGUEIRO M, Greer JB, Szigethy E
    Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:430-439.
    PubMed     Abstract available


  393. LEWIS JD, Abreu MT
    Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:398-414.
    PubMed     Abstract available


  394. ABRAHAM C, Dulai PS, Vermeire S, Sandborn WJ, et al
    Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:374-388.
    PubMed     Abstract available


  395. SARTOR RB, Wu GD
    Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
    Gastroenterology. 2017;152:327-339.
    PubMed     Abstract available


  396. MAHADEVAN U, McConnell RA, Chambers CD
    Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017;152:451-462.
    PubMed     Abstract available


  397. VELAYOS F, Kathpalia P, Finlayson E
    Changing Paradigms in Detection of Dysplasia and Management of Patients With Inflammatory Bowel Disease: Is Colectomy Still Necessary?
    Gastroenterology. 2017;152:440-450.
    PubMed     Abstract available


  398. PANES J, Jairath V, Levesque BG
    Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:362-373.
    PubMed     Abstract available


  399. CHEIFETZ AS, Gianotti R, Luber R, Gibson PR, et al
    Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:415-429.
    PubMed     Abstract available


  400. STAPPENBECK TS, McGovern DP
    Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease.
    Gastroenterology. 2017;152:322-326.
    PubMed     Abstract available


  401. COLOMBEL JF, Narula N, Peyrin-Biroulet L
    Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:351-361.
    PubMed     Abstract available


  402. RIEDER F, Fiocchi C, Rogler G
    Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:340-350.
    PubMed     Abstract available


    January 2017
  403. ROSEN MJ, Karns R, Vallance JE, Bezold R, et al
    Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-only Crohn's Disease in Treatment-naive Pediatric Patients.
    Gastroenterology. 2017 Jan 26. pii: S0016-5085(17)30073.
    PubMed     Abstract available


  404. POPP V, Gerlach K, Mott S, Turowska A, et al
    Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
    Gastroenterology. 2017;152:176-192.
    PubMed     Abstract available


    December 2016
  405. VAZIRI H, Anderson JC
    Is Chromoendoscopy Superior to Standard Colonoscopy for Long-term Surveillance of Patients With Inflammatory Bowel Disease?
    Gastroenterology. 2016 Dec 28. pii: S0016-5085(16)35525.
    PubMed    


  406. COLOMBEL JF, Mahadevan U
    Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms.
    Gastroenterology. 2016 Dec 10. pii: S0016-5085(16)35464.
    PubMed    


    November 2016
  407. SHIRAISHI T, Shoji H, Akazawa Y
    Gingival Carcinoma in a Patient With Ulcerative Colitis?
    Gastroenterology. 2016 Nov 25. pii: S0016-5085(16)34955.
    PubMed    


  408. FRANKE A
    Inflammatory Bowel Disease: A Global Disease That Needs a Broader Ensemble of Populations.
    Gastroenterology. 2016 Nov 23. pii: S0016-5085(16)35395.
    PubMed    


  409. YANG Y, Owyang C, Wu GD
    East Meets West: The Increasing Incidence of Inflammatory Bowel Disease in Asia as a Paradigm for Environmental Effects on the Pathogenesis of Immune-Mediated Disease.
    Gastroenterology. 2016 Nov 1. pii: S0016-5085(16)35281.
    PubMed    


    October 2016
  410. EL-MATARY W
    Risk of Attenuated Live Vaccine-Induced Infection in Infants of Mothers Receiving Anti-Tumor Necrosis Factor Agents for Inflammatory Bowel Disease.
    Gastroenterology. 2016 Oct 31. pii: S0016-5085(16)35187.
    PubMed    


  411. SANCHEZ-GUILLEN L, Blanco-Antona F, Millan-Scheiding M
    An Unusual Case of Intestinal Obstruction in Ulcerative Colitis.
    Gastroenterology. 2016 Oct 31. pii: S0016-5085(16)34813.
    PubMed    


  412. SMITH PD, Elson CO
    Elucidating the Role of the IL-10 Receptor in Mucosal Inflammation Uncovers a Potential Treatment for Infantile Inflammatory Bowel Disease.
    Gastroenterology. 2016 Oct 27. pii: S0016-5085(16)35279.
    PubMed    


  413. KAPLAN GG, Ng SC
    Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.
    Gastroenterology. 2016 Oct 25. pii: S0016-5085(16)35267.
    PubMed     Abstract available


    September 2016
  414. BAMIAS G, Rivera-Nieves J
    Targeting S1P Receptors, A New Mechanism of Action for Inflammatory Bowel Disease Therapy.
    Gastroenterology. 2016 Sep 29. pii: S0016-5085(16)35120.
    PubMed    


  415. KHANNA R, Jairath V
    Treatment Targets in Ulcerative Colitis.
    Gastroenterology. 2016 Sep 29. pii: S0016-5085(16)35123.
    PubMed    


  416. BRANT SR, Okou DT, Simpson CL, Cutler DJ, et al
    Genome-wide Association Study Identifies African-Specific Susceptibility Loci in African Americans with Inflammatory Bowel Disease.
    Gastroenterology. 2016 Sep 28. pii: S0016-5085(16)35127.
    PubMed     Abstract available


  417. PIPER MS, Waljee A, Stidham R
    Operate or Medicate: Understanding Surgical Risks in the Elderly with Inflammatory Bowel Disease.
    Gastroenterology. 2016 Sep 28. pii: S0016-5085(16)35122.
    PubMed    


    May 2016
  418. SCHREIBER S, Vermeire S
    How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel Diseases.
    Gastroenterology. 2016;150:1061-6.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: